Profound Medical Corp Stock Today
| PROF Stock | USD 6.23 0.21 3.26% |
PerformanceWeakest
| Odds Of DistressLow
|
Profound Medical is trading at 6.23 as of the 12th of February 2026. This is a 3.26% down since the beginning of the trading day. The stock's lowest day price was 6.0. Profound Medical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 14th of November 2025 and ending today, the 12th of February 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 9th of June 2016 | Category Healthcare | Classification Health Care |
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. The company has 36.29 M outstanding shares of which 1.31 M shares are at this time shorted by private and institutional investors with about 5.77 trading days to cover. More on Profound Medical Corp
Moving together with Profound Stock
Moving against Profound Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Profound Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsProfound Medical utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Profound Medical's leverage profile, showing how much of Profound Medical's resources are funded through borrowing.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Profound Medical Corp (PROF) is traded on NASDAQ Exchange in USA and employs 142 people. Profound Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 230.82 M. Profound Medical Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 36.29 M outstanding shares of which 1.31 M shares are at this time shorted by private and institutional investors with about 5.77 trading days to cover.
Profound Medical Corp currently holds about 46.21 M in cash with (23.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21.
Check Profound Medical Probability Of Bankruptcy
Ownership AllocationProfound Medical owns a total of 36.29 Million outstanding shares. 30% of Profound Medical Corp outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Profound Ownership Details
Profound Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Carolina Wealth Advisors, Llc | 2025-06-30 | 2 K |
Profound Medical Historical Income Statement
Profound Stock Against Markets
Profound Medical Corporate Management
| Arun MBA | Chairman CEO | Profile | |
| Hartmut Warnken | Senior Alliances | Profile | |
| Jacques Cornet | Senior Sonalleve | Profile | |
| Stephen Kilmer | Investor Relations | Profile | |
| Mathieu Burtnyk | Senior TULSAPRO | Profile | |
| Thomas MBA | Chief Officer | Profile | |
| Abbey Goodman | Chief Global | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Profound have expansion opportunities? Factors like these will boost the valuation of Profound Medical. Anticipated expansion of Profound directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Profound Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.32) | Revenue Per Share | Quarterly Revenue Growth 0.868 | Return On Assets | Return On Equity |
Investors evaluate Profound Medical Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Profound Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Profound Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Profound Medical's market price signifies the transaction level at which participants voluntarily complete trades.